17Aug/21
Times of PROTAC Explosion: Mechanism, Drugs, and 20-year Revolution
Recently, Pfizer and Arvinas jointly announced that they have reached an agreement to co-develop and promote the PROTAC protein degrader ARV-471. Arvinas will receive $650 million in upfront payments and potentially upRead More…